News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Lopatin Uri A
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/07/2022 |
SC 13D
| Lopatin Uri A reports a 9.1% stake in Pardes Biosciences, Inc. |
| 02/02/2022 |
4
| Lopatin Uri A (President and CEO) has filed a Form 4 on PARDES BIOSCIENCES, INC.|
Txns:
| Granted 421,000 options to buy
@ $11.32, valued at
$4.8M
|
|
| 12/27/2021 |
3
| Lopatin Uri A (President and CEO) has filed a Form 3 on PARDES BIOSCIENCES, INC. |
| 04/02/2019 |
4
| Lopatin Uri A (Chief Medical Officer) has filed a Form 4 on ASSEMBLY BIOSCIENCES, INC.|
Txns:
| Granted 13,750 shares
@ $0
Granted 27,500 options to buy
@ $19.69, valued at
$541.5k
|
|
| 09/07/2018 |
4
| Lopatin Uri A (Chief Med. Off., VP Res. Dev.) has filed a Form 4 on ASSEMBLY BIOSCIENCES, INC.|
Txns:
| Sold 15,204 shares
@ $40.0912, valued at
$609.5k
Sold 336 shares
@ $40.006, valued at
$13.4k
|
|
| 03/30/2018 |
4
| Lopatin Uri A (Chief Med. Off., VP Res. Dev.) has filed a Form 4 on ASSEMBLY BIOSCIENCES, INC.|
Txns:
| Granted 7,500 shares
@ $0
Granted 15,000 options to buy
@ $49.14, valued at
$737.1k
|
|
| 03/31/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/11/2016 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities |
| 10/07/2014 |
4/A
| Lopatin Uri A (Chief Med. Off., VP Res. Dev.) has filed a Form 4 on ASSEMBLY BIOSCIENCES, INC.|
Txns:
| Granted 160,000 options to buy
@ $0 |
|
| 07/14/2014 |
4
| Lopatin Uri A (Chief Med. Off., VP Res. Dev.) has filed a Form 4 on ASSEMBLY BIOSCIENCES, INC.|
Txns:
| Granted 160,000 options to buy
@ $0 |
|
|
|